To investigate the potential clinical relevance of Tks4 and Tks5 expression in human melanoma, we performed immunohistochemical (IHC) analysis of tissue microarrays containing human melanoma specimens (total of 110 cases for Tks4 and 165 cases for Tks5 analysis). This evidence concerns the gene SH3PXD2B and melanoma.